E78.2

Applicable To

• Broad- or floating-betalipoproteinemia

• Combined hyperlipidemia NOS

• Elevated cholesterol with elevated triglycerides NEC

• Fredrickson’s hyperlipoproteinemia, type IIb or III

• Hyperbetalipoproteinemia with prebetalipoproteinemia

• Hypercholesteremia with endogenous hyperglyceridemia

• Hyperlipidemia, group C

• Tubo-eruptive xanthoma

• Xanthoma tuberosum

Approximate Synonyms

• Diabetes type 1 with hyperliidemia

• Diabetes type 2 with hyperlipidemia

• Eruptive xanthoma

• Hyperlipidemia, mixed high blood fats)

• Mixed hyperlipidemia associated with type 1 diabetes mellitus

• Mixed hyperlipidemia associated with type 2 diabetes mellitus

• Mixed hyperlipidemia due to type 1 diabetes mellitus

• Mixed hyperlipidemia due to type 2 diabetes mellitus

• Tuberous xanthoma

• Xanthoma tuberosum

Clinical Information

• A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.

• A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma cholesterol and/or triglycerides. Multiple genes on different chromosomes may be involved, such as the major late transcription factor upstream stimulatory factors) on chromosome 1.

• Type iib hyperlipoproteinemia is caused by mutation in the receptor-binding domain of apolipoprotein b-100 which is a major component of low-density lipoproteins and very-low-density lipoproteins resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and hypertriglyceridemia combined hyperlipidemia).

Details

• E78.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM E78.2 became effective on October 1, 2022.

• This is the American ICD-10-CM version of E78.2 – other international versions of ICD-10 E78.2 may differ.